Acute Myeloid Leukemia | Tumor

CURE’s acute myeloid leukemia page features the latest cancer news and updates on acute myeloid leukemia. Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in acute myeloid leukemia.

My Journey Through Acute Myeloid Leukemia With My Friend

August 23rd 2019, 8:00pm

Article

What are the odds that my friend, Michael, would be afflicted with the same rare disease that I had?

Laughing From My Belly: How Humor Helped My Cancer Recovery

August 17th 2019, 10:00pm

Article

Some of the greatest doctors in the world were responsible for my survival and recovery from acute myeloid leukemia…but the Three Stooges, W.C Fields, Abbott and Costello, Laurel and Hardy and The Marx Brothers played a major role as well.

Friday Frontline: July 12, 2019

July 12th 2019, 9:41pm

Article

From Trump’s executive order regarding drug prices to today’s top performers and athletes, here’s what is making headlines in the cancer space this week.

Former 'SNL' Comedian Publishes a Children's Book About Supporting Friends Through Illness

June 4th 2019, 5:32pm

Article

In a talk about her new book, Vanessa Bayer explains how leukemia contributed to her comic perspective and sense of empathy.

FDA Panel Recommends Against Quizartinib Approval for Acute Myeloid Leukemia

May 15th 2019, 6:24pm

Article

The Food and Drug Administration’s Oncologic Drugs Advisory Committee voted against approving a new drug application for quizartinib for adult patients with relapsed/refractory FLT3-ITD–positive AML.

FDA Approves Tibsovo for Frontline IDH1-Mutant Acute Myeloid Leukemia

May 2nd 2019, 11:12pm

Article

The FDA has approved a supplemental new drug application for Tibsovo as a single agent for the first-line treatment of adult patients with IDH1-mutant acute myeloid leukemia who are 75 years and older or are ineligible to receive intensive chemotherapy.

FDA Grants Priority Review to Tibsovo for Acute Myeloid Leukemia Subgroup

February 20th 2019, 7:53pm

Article

The Food and Drug Administration granted a priority review to Tibsovo (ivosidenib) for the treatment of patients with newly diagnosed acute myeloid leukemia (AML) with an IDH1 mutation who are not eligible for standard therapy.

FDA Approves Xospata and Companion Diagnostic Test for Leukemia Treatment

November 29th 2018, 12:53am

Article

The Food and Drug Administration (FDA) approved Xospata (gilteritinib) for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) who have a FLT3 mutation that is detected by an FDA-approved test, according to the agency.

Striking a Match for Stem Cell Transplants

September 14th 2018, 6:31pm

Article

Techniques open a field of opportunity for stem cell transplant recipients.

FDA Approves Nivestym for Acute Myeloid Leukemia and More

July 23rd 2018, 4:49pm

Article

The Food and Drug Administration approved Nivestym (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for five eligible indications.